SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001069530-22-000033
Filing Date
2022-08-04
Accepted
2022-08-04 16:01:03
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sava-20220630x10q.htm   iXBRL 10-Q 2241683
2 EX-10.1 sava-20220630xex10_1.htm EX-10.1 4632
3 EX-31.1 sava-20220630xex31_1.htm EX-31.1 25547
4 EX-31.2 sava-20220630xex31_2.htm EX-31.2 25246
5 EX-32.1 sava-20220630xex32_1.htm EX-32.1 20428
6 GRAPHIC sava-20220630x10qg001.jpg GRAPHIC 28862
7 GRAPHIC sava-20220630x10qg002.jpg GRAPHIC 30381
8 GRAPHIC sava-20220630x10qg003.jpg GRAPHIC 46460
9 GRAPHIC sava-20220630x10qg004.jpg GRAPHIC 31851
10 GRAPHIC sava-20220630x10qg005.jpg GRAPHIC 93477
  Complete submission text file 0001069530-22-000033.txt   7490737

Data Files

Seq Description Document Type Size
11 EX-101.SCH sava-20220630.xsd EX-101.SCH 33070
12 EX-101.CAL sava-20220630_cal.xml EX-101.CAL 43114
13 EX-101.DEF sava-20220630_def.xml EX-101.DEF 118884
14 EX-101.LAB sava-20220630_lab.xml EX-101.LAB 253951
15 EX-101.PRE sava-20220630_pre.xml EX-101.PRE 247261
61 EXTRACTED XBRL INSTANCE DOCUMENT sava-20220630x10q_htm.xml XML 1298052
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 221136361
SIC: 2834 Pharmaceutical Preparations